liposomal glutathione nafld liver disease study Metabolic dysfunction-associated steatotic disease-induced changes in the antioxidant system: a review | Archives of Toxicology Targeted therapeutics and novel signaling

Dermatol 2009: 1:115119

The mitochondria essentially burn themselves out, leading to the profound, crushing fatigue characteristic of these conditions

Addressing the limitations of conventional therapies, DDS offers a three-dimensional therapeutic paradigm through interdisciplinary innovations in material science and pharmacokinetics, particularly for gout and hyperuricemia management ( 3.6.1 Organ-specific targeted delivery Surface-modified nanocarriers (e.g., nanoparticles and liposomes) enable precise drug enrichment in renal proximal tubules or hepatocytes ( 3.6.2 Spatiotemporally controlled sustained-release platforms Microsphere/liposome systems: PLGA- or lipid-encapsulated uricase formulations achieve weeks-to-months sustained release, reducing injection frequency and improving adherence in chronic regimens ( 2 composites) trigger drug release in acidic microenvironments (e.g., inflammation sites and crystal deposits), enhancing local efficacy ( 3.6.3 Multimodal synergistic therapeutics DDS enables urate-lowering + anti-inflammatory combinatorial strategies through co-delivery systems

Kim MP, Swisher SG

& Dye, L

Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes